Windy City Media Group Frontpage News
Celebrating 30 Years of Gay Lesbian Bisexual and Trans News
home search facebook twitter join
Gay News Sponsor Windy City Times 2019-09-18
DOWNLOAD ISSUE
About WCMG Publications News Index  Entertainment Features Bars & Clubs Calendar Videos Advertisers OUT! Guide    Marriage

Sponsor
Sponsor

  WINDY CITY TIMES

Senators inquire sbout PrEP pricing and patents
by Matt Simonette
2019-04-26

facebook twitter google +1 reddit email


U.S. Sen. Tammy Duckworth ( D-IL ) is among seven U.S. senators who were signatories on an April 23 letter asking Health and Human Services Secretary Alex M. Azar and Centers for Disease Control and Prevention ( CDC ) Director Robert Redfield, M.D., about the specifics of patents, licensing and manufacturing of the oral medication Truvada.

The high cost of Truvada, which has proven to be over 90 percent effective in preventing new HIV infections, has been a deterrent in its wide adoption among consumers. A bottle of the medication costs between $1,500-2,000 per month. Truvada is manufactured by Foster City, California-based Gilead Pharmaceuticals.

A coalition of activists have recently called attention to a key conundrum surrounding that price-point: The federal government paid for the research and development that went into Truvada's PrEP usage, raising the question of why the medication is priced so high. The patents are held by the federal government as well.

The senators wrote in their April 23 letter that, "PrEP was invented—and patented—by scientists working for the CDC. These patents are held by the United States of America, as represented by the Secretary of the Department of Health and Human Services.

"Based on an analysis of these patents and the FDA-approved prescribing information for Truvada, Gilead appears to potentially be marketing a prescription drug for usages that are patented by the government."

In a statement to Windy City Times, Duckworth said, "U.S. taxpayers paid for the development of this life-saving drug and own the rights to it. That is why it's so outrageous that a private pharmaceutical company is gouging consumers and making it difficult for many Americans to afford it. My colleagues and I are demanding answers on how this happened, and to ensure Gilead both lowers Truvada's cost and is held accountable for its actions."

PrEP is a central component to several initiatives to eliminate new HIV transmissions, among them the state of Illinois' Getting to Zero campaign.

Additional signatories on the letter included U.S. Sens. Tammy Baldwin ( D-WI ), Bernie Sanders ( I-VT ), Richard Blumenthal ( D-CT ), Ben Cardin ( D-MD ), Chris Van Hollen ( D-MD ) and Debbie Stabenow ( D-MI ); Stabenow led the inquiry. Redfield and Azar have until May 7 to respond.


facebook twitter google +1 reddit email





Windy City Media Group does not approve or necessarily agree with the views posted below.
Please do not post letters to the editor here. Please also be civil in your dialogue.
If you need to be mean, just know that the longer you stay on this page, the more you help us.



Copyright © 2019 Windy City Media Group. All rights reserved.
Reprint by permission only. PDFs for back issues are downloadable from
our online archives. Single copies of back issues in print form are
available for $4 per issue, older than one month for $6 if available,
by check to the mailing address listed below.

Return postage must accompany all manuscripts, drawings, and
photographs submitted if they are to be returned, and no
responsibility may be assumed for unsolicited materials.
All rights to letters, art and photos sent to Nightspots
(Chicago GLBT Nightlife News) and Windy City Times (a Chicago
Gay and Lesbian News and Feature Publication) will be treated
as unconditionally assigned for publication purposes and as such,
subject to editing and comment. The opinions expressed by the
columnists, cartoonists, letter writers, and commentators are
their own and do not necessarily reflect the position of Nightspots
(Chicago GLBT Nightlife News) and Windy City Times (a Chicago Gay,
Lesbian, Bisexual and Transegender News and Feature Publication).

The appearance of a name, image or photo of a person or group in
Nightspots (Chicago GLBT Nightlife News) and Windy City Times
(a Chicago Gay, Lesbian, Bisexual and Transgender News and Feature
Publication) does not indicate the sexual orientation of such
individuals or groups. While we encourage readers to support the
advertisers who make this newspaper possible, Nightspots (Chicago
GLBT Nightlife News) and Windy City Times (a Chicago Gay, Lesbian
News and Feature Publication) cannot accept responsibility for
any advertising claims or promotions.

 

 

 

TRENDINGBREAKINGPHOTOS

Sponsor
Sponsor
Sponsor
Sponsor


 



About WCMG Publications News Index  Entertainment Features Bars & Clubs Calendar Videos Advertisers OUT! Guide    Marriage


About WCMG      Contact Us      Online Front  Page      Windy City  Times      Nightspots      OUT! Guide     
Identity      BLACKlines      En La Vida      Archives      Subscriptions      Distribution      Windy City Queercast     
Queercast Archives      Advertising  Rates      Deadlines      Advanced Search     
Press  Releases      Event Photos      Join WCMG  Email List      Email Blast     
Upcoming Events      Todays Events      Ongoing Events      Post an Event      Bar Guide      Community Groups      In Memoriam      Outguide Categories      Outguide Advertisers      Search Outguide      Travel      Dining Out      Blogs      Spotlight  Video     
Classifieds      Real Estate      Place a  Classified     

Windy City Media Group publishes Windy City Times,
The Bi-Weekly Voice of the Gay, Lesbian, Bisexual and Trans Community.
5315 N. Clark St. #192, Chicago, IL 60640-2113 • PH (773) 871-7610 • FAX (773) 871-7609.